Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09DLP
|
||||
Former ID |
DIB002636
|
||||
Drug Name |
Tramiprosate
|
||||
Synonyms |
Alzhemed; Cerebril; Homotaurine; Vivimind; LU-02659; NC-531; NC-758; Tramiprosate (stroke), Neurochem; Tramiprosate (Alzheimer's disease), Neurochem; 3APS
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Alzheimer disease [ICD9: 331; ICD10:G30] | Phase 3 | [1] | ||
Company |
Neurochem
|
||||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C3H9NO3S
|
||||
Canonical SMILES |
S(=O)(=O)(O)CCCN
|
||||
CAS Number |
CAS 3687-18-1
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Amyloid beta A4 protein | Target Info | Antagonist | [2] | |
KEGG Pathway | Notch signaling pathway | ||||
Alzheimer's disease | |||||
Reactome | Nuclear signaling by ERBB4 | ||||
Degradation of the extracellular matrix | |||||
Regulated proteolysis of p75NTR | |||||
NRIF signals cell death from the nucleus | |||||
Activated NOTCH1 Transmits Signal to the Nucleus | |||||
Constitutive Signaling by NOTCH1 PEST Domain Mutants | |||||
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | |||||
EPH-ephrin mediated repulsion of cells | |||||
WikiPathways | Notch Signaling Pathway | ||||
Signaling by ERBB4 | |||||
Signaling by NOTCH3 | |||||
Signaling by NOTCH4 | |||||
Signaling by NOTCH1 | |||||
Signaling by NOTCH2 | |||||
Notch Signaling Pathway | |||||
Alzheimers Disease | |||||
Signalling by NGF | |||||
References | |||||
REF 1 | ClinicalTrials.gov (NCT00314912) Open-Label Extension of the Phase III Study With Tramiprosate (3APS) in Patients With Mild to Moderate Alzheimer's Disease. U.S. National Institutes of Health. | ||||
REF 2 | Targeting soluble Abeta peptide with Tramiprosate for the treatment of brain amyloidosis. Neurobiol Aging. 2007 Apr;28(4):537-47. Epub 2006 May 3. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.